Aniket Badkar

Aniket Badkar has extensive experience in the pharmaceutical industry, with a focus on biologics drug substance and drug product formulation development. Aniket currently holds the position of Director of Formulation and Drug Product Development at Vir Biotechnology, Inc. In this role, they lead drug product development for Vir's pipeline of products, which includes therapeutic modalities such as antibodies, cell therapies, viral vectors, and nucleic acids.

Prior to their current role, Aniket worked at AbbVie as the Director of Neurotoxins and Biologics Product Development. Aniket held this position from May 2020 to November 2022.

Before joining AbbVie, Aniket held various roles at Allergan from 2015 to 2020, including Director of Biologics Product Development and Associate Director of Biologics Product Development.

Aniket's previous experience also includes working at Zoetis Inc. as a Principal Scientist from 2011 to 2015. In this role, they led the formulation and process development of CYTOPOINT™, the first monoclonal antibody licensed to help control atopic dermatitis in dogs. Aniket also worked on the formulation and process development of other biologic candidates for multiple species.

Prior to their time at Zoetis, Aniket worked at Merck as an Associate Principal Scientist from 2009 to 2011 and as a Senior Scientist from 2006 to 2009.

Aniket's career in the pharmaceutical industry began as a Graduate Student (Ph.D.) at Mecer University from 2001 to 2006. Aniket also gained industry experience as a Summer Intern at Pfizer in 2004.

Aniket Badkar completed their Bachelor of Science (B.S.) in Pharmacy at the University of Mumbai from 1997 to 2001. Following this, they pursued a Ph.D. in Pharmaceutical Sciences at Mercer University - College of Pharmacy from 2001 to 2006.